Founded in 2013, Geneseeq Technology – Nanjing has rapidly emerged as a pioneering force in the clinical application of high-throughput sequencing technology. Specializing in molecular diagnostics for tumor precision medicine, the company has been at the forefront of innovation within the “gene and cell” sector for over a decade, establishing itself as a key player within the Nanjing Jiangbei New Area.

Geneseeq Technology is more than just a company; it is a Chinese unicorn startup that serves as a benchmark in the tumor precision medicine industry. Recognized as a national high-tech enterprise and a “Small Giant” firm, Geneseeq exemplifies technological excellence and innovation. The company, which employs more than 1,500 committed professionals, has expanded its influence to 25 Chinese provinces and cities and has tested more than 10,000 tumor samples to date.